BSE filing, NSE: THYROCARE. Summary written from the filing by ALFA Finder's alert engine.
Thyrocare Technologies Ltd: key numbers
- Share price
- ₹514.95
- Market cap
- ₹8,196 Cr
- Revenue (annual)
- ₹829.0 Cr
- Net profit (annual)
- ₹163.0 Cr
- P/E (TTM)
- 46.5×Sector 52.0×
- Promoter holding
- 51.02%-9.90% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thyrocare Technologies Ltd
All →Thyrocare Technologies Results Update
Thyrocare Technologies reported Q2FY27 consolidated revenue of Rs 270.8 Cr, up 25.1% YoY, with PAT before exceptions of Rs 60.2 Cr. The press release also notes a Rs 45 Cr non-cash NHL impairment tied to a proposed divestment.
Thyrocare Technologies Q2 FY27 Results: Net Profit ₹15.2 Cr, Down 68.2% YoY
Thyrocare Technologies Ltd reported revenue from operations of ₹270.8 Cr (+25.1% YoY) and net profit of ₹15.2 Cr (-68.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹15.2 Cr · -68.2% YoY
Thyrocare Technologies Board Meeting Date
Thyrocare Technologies intimated that its Board meeting is scheduled for 29 Oct 2026 to consider Q2/H1 FY27 results. No financial figures or decisions are reported in this prior intimation.
Thyrocare Technologies Other Announcement
Thyrocare Technologies filed its quarterly shareholding pattern for the period ended September 30, 2026, including a note regarding a prior promoter group amalgamation.
Thyrocare Technologies Annual General Meeting
Thyrocare Technologies initiated a postal ballot for two resolutions: purchasing property from its subsidiary, Nueclear Healthcare, and selling its investment in Nueclear Healthcare.
Thyrocare Technologies Annual General Meeting
Thyrocare seeks shareholder approval via postal ballot for the purchase of land and building and the divestment of its subsidiary, Nueclear Healthcare Limited.
- Value
- ₹162.0 Cr
Other dividend announcements
All →Godrej Consumer Products Dividend
Godrej Consumer Products declared an interim dividend of Rs. 5 per equity share on October 29, 2026. This returns capital to shareholders alongside the half-year results.
Laurus Labs Dividend
Laurus Labs approved a Re. 1.00 per share interim dividend for FY 2026-27. Record date is November 6, 2026; payment on or after November 19, 2026.
Symphony Dividend
Symphony Limited declared a 2nd interim dividend of Rs. 2 per equity share for FY 2026-27, with record date 04-11-2026. Payment is proposed by 25-11-2026.
Privi Speciality Chemicals Dividend
Privi Speciality Chemicals declared an interim dividend of Rs 5 per equity share for FY 2026-27 at its 29 October 2026 board meeting. Record date is 04 November 2026 and payment by 25 November 2026.
Vaibhav Global Dividend
Vaibhav Global fixed 4 November 2026 as the record date for its second interim dividend for FY 2026-27. Shareholders on that date are eligible for the payment.
Sasken Technologies Dividend
Sasken Technologies declared an interim dividend of Rs.12 per equity share for FY2026-27, alongside Q2 audited results. Record date is November 3, 2026, with payment on or before November 26, 2026.